Analysts probed DSA bookings strength and book-to-bill ratio amid stronger-than-expected demand in the segment.
1 report, 0 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts probed DSA bookings strength and book-to-bill ratio amid stronger-than-expected demand in the segment.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
DSA
Czech company
-
Charles River Laboratories
major US biomedical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet